Expert Review of Clinical Immunology

Article	Citations
Assessing the EULAR/ACR classification criteria for patients with systemic lupus erythematosus	91
Biologicals for moderate-to-severe plaque type psoriasis in pediatric patients	77
Managing acute COVID-19 in immunocompromised pediatric patients	76
Genetic syndromes and autoimmunity: what do we know? Focus on Down and Turner syndrome	76
Pharmacogenetics of childhood uncontrolled asthma	63
What is the full potential of baricitinib in treating patients with COVID-19?	58
Impact of immunotherapies on COVID-19 outcomes in multiple sclerosis patients	47
A review of current biomarkers in chronic rhinosinusitis with or without nasal polyps	43
The evolving role of JAK inhibitors in the treatment of inflammatory bowel disease	42
Ex vivo and in vivo T-cell depletion in allogeneic transplantation: towards less or non-cytotoxic conditioning regimens	41
Vitamin D as disease-modifying therapy for multiple sclerosis?	35
Clinical updates in neoadjuvant immunotherapy for melanoma before surgery	30
Predicting lupus low disease activity state and remission in SLE: novel insights	30
Abdeg technology for the treatment of myasthenia gravis: efgartigimod drug experience	28
Targeting the microbiome in Crohn’s disease	28
Broadening the clinical spectrum of giant cell arteritis: from the classic cranial to the predominantly extracranial pattern of the disease	24
A critical review of dupilumab for adult patients with prurigo nodularis	24
Precision medicine in the allergy clinic: the application of component resolved diagnosis	24
Evaluation of ruxolitinib cream 1.5% as an at-home therapy for repigmentation in non-segmental vitiligo	24
Responses of patients with juvenile idiopathic arthritis to methotrexate: a genomic outlook	24
Anoikis and SPP1 in idiopathic pulmonary fibrosis: integrating bioinformatics, cell, and animal studies to explore prognostic biomarkers and PI3K/AKT signaling regulation	23
Secukinumab for children and adolescents with enthesitis-related arthritis and psoriatic arthritis: lessons from treatment in adults and the way forward	22
How could our genetics impact COVID-19 vaccine response?	22
Safety and efficacy of epicutaneous immunotherapy with DBV712 (peanut patch) in peanut allergy	22
Cellular mechanisms and clinical applications for phenocopies of inborn errors of immunity: infectious susceptibility due to cytokine autoantibodies	21

An immunologist’s guide to immunosenescence and its treatment	21
Challenges and management of childhood noninfectious chronic uveitis	20
Examining the autoimmune aspects of frontal fibrosing alopecia	20
Bradford Hill and breast implant illness: no evidence for causal association with breast implants	20
The Impact of Preeclampsia in Lupus Nephritis	20
Assessing the potential of epigenetic targets as biomarkers in the diagnosis and treatment of rheumatoid arthritis	19
BRAF inhibitors and their immunological effects in malignant melanoma	19
The role of IL-6 and IL-6 blockade in COVID-19	18
The multidisciplinary approach to diagnosing inborn errors of immunity: a comprehensive review of discipline-based manifestations	18
Inducibility or predestination? Queries and concepts around drug-free remission in rheumatoid arthritis	16
Telemedicine beyond the pandemic: challenges in the pediatric immunology clinic	16
Olfactory dysfunction in chronic rhinosinusitis: insights into the underlying mechanisms and treatments	16
Perspective: the nose and the stomach play a critical role in the NZACE2-Pātari* (modified ACE2) drug treatment project of SARS-CoV-2 infection	16
Tofacitinib for the treatment of active ankylosing spondylitis in adults	16
A successful linkage of a named patient products of sublingual immunotherapy-dispensing registry to French healthcare insurance database (SNDS): methodological constitution of the EfficAPSI cohort	16
Efficacy of biologic agents for palmoplantar psoriasis: a systematic review and network meta-analysis	15
Immunobiology and treatment of cutaneous T-cell lymphoma	15
Will SARS-CoV-2 impact the incidence and nature of other respiratory infections?	15
Bimekizumab for the treatment of psoriatic arthritis	14
Aleukemic variant of T-cell large granular lymphocyte leukemia in patients with rheumatoid arthritis - diagnostically challenging subtype	14
Eosinophilic esophagitis: does age matter?	14
Innovative treatments for severe uncontrolled chronic rhinosinusitis with nasal polyps	13
Machine learning method for the cellular phenotyping of nasal polyps from multicentre tissue scans	13
Molecular genotyping versus serological diagnosis for RH blood group typing in sickle cell patients	13
The methylenetetrahydrofolate reductase 1298 A>C polymorphism is associated with an increased risk of inflammatory bowel disease: evidence from a meta-analysis	13
Generalized pustular psoriasis: current management status and unmet medical needs in Japan	13
An updated review on Mendelian susceptibility to mycobacterial diseases– a silver jubilee celebration of its first genetic diagnosis	13
Proportion of T follicular helper cells in peripheral blood of rheumatoid arthritis patients: a systematic review and meta-analysis	13
Colorectal medullary carcinoma: a pathological subtype with intense immune response and potential to benefit from immune checkpoint inhibitors	12
The role of fibroblast in chronic rhinosinusitis with nasal polyps: a key player in the inflammatory process	12
A prospective single-arm study on the efficacy and safety of short-course oral corticosteroids followed by topical corticosteroids in patients with severe chronic rhinosinusitis with nasal polyps	12
The role of immune reconstitution in relapse after allogeneic hematopoietic stem cell transplantation	12
Lymphocyte-C-reactive protein ratio combined with albumin upon admission predicts coronary artery dilation and aneurysm formation in pediatric patients with Kawasaki disease: a retrospective cohort st	12
Pan-cancer analysis of the prognostic significance of ACKR2 expression and the related genetic/epigenetic dysregulations	12
Peanut (Arachis hypogaea) allergen powder-dnfp for the mitigation of allergic reactions to peanuts in children and adolescents	12
Prognostic factors for post-operative outcomes in chronic rhinosinusitis with nasal polyps: a systematic review	12
Pioglitazone as a potential modulator in autoimmune diseases: a review on its effects in systemic lupus erythematosus, psoriasis, inflammatory bowel disease, and multiple sclerosis	12
Epinephrine treatment of food-induced and other cause anaphylaxis in United States and Canadian Emergency Departments: a systematic review and meta-analysis	12
Update on virus-induced asthma exacerbations	11
A review of disease burden and clinical management for generalized pustular psoriasis in China	11
New therapeutic concepts against ischemia-reperfusion injury in organ transplantation	11
Anifrolumab: first biologic approved in the EU not restricted to patients with a high degree of disease activity for the treatment of moderate to severe systemic lupus erythematosus	11
Immune dysfunction in inborn errors of immunity causing malignancies	11
Model-based computational precision medicine to develop combination therapies for autoimmune diseases	11
Utilizing type I interferon expression in the identification of antiphospholipid syndrome subsets	11
Why do drug treatments fail in Sjögren’s disease? Considerations for treatment, trial design and interpretation of clinical efficacy	10
Personalizing therapy selection in inflammatory bowel disease	10
A critical evaluation of nemolizumab for prurigo nodularis	10
Efficacy and safety of subcutaneous immunotherapy with polymerized allergen mixtures in polyallergic patients – ARES observational study	10
Growth differentiation factor-15 as an emerging biomarker for identifying myositis	10

An update on VEXAS syndrome	10
Biological drugs for the treatment of children with chronic spontaneous urticaria	10
Risk of infections in psoriasis: assessment and challenges in daily management	9
More than a random association between chronic obstructive pulmonary disease and psoriatic arthritis: shared pathogenic features and implications for treatment	9
Improving prediction of disease outcome for inflammatory bowel disease: progress through systems medicine	9
Ruxolitinib as the first post-steroid treatment for acute and chronic graft-versus-host disease	9
Novel therapeutic approaches for cutaneous T cell lymphomas	9
Machine learning approaches to improve disease management of patients with rheumatoid arthritis: review and future directions	9
What are the prospects for antiplatelet agents for thromboprophylaxis in antiphospholipid syndrome?	9
Could we co-opt the cannabinoid system for asthma therapy?	8
An evaluation of anifrolumab for use in adults with systemic lupus erythematosus	8
Voclosporin: a novel calcineurin inhibitor for the management of lupus nephritis	8
Translational characterization of immune pathways in inflammatory bowel disease: insights for targeted treatments	8
Re-evaluation of nailfold capillaroscopy in discriminating primary from secondary Raynaud’s phenomenon and in predicting systemic sclerosis: a randomised observational prospective cohort study	8
How suitable is intravenous tocilizumab for the treatment of Graves’ ophthalmopathy?	8
Clinical guide to eosinophilic fasciitis: straddling dermatology and rheumatology	8
Current evaluation and management of patients with chronic rhinosinusitis and nasal polyps	8
The (apparent) antibody paradox in COVID-19	8
Pathophysiology of rejection in kidney transplantation	8
Could small molecules be used in combination with biologics for inflammatory bowel disease?	8
The role of genetics in food allergy	8
Optimizing the treatment of cytomegalovirus infection in allo-HSCT recipients	8
Systemic therapy in juvenile localized scleroderma	8
Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician	8
How best to manage relapse and remission in ANCA-associated vasculitis	8
Innovative cell therapies for systemic sclerosis: available evidence and new perspectives	8
Comparison of high- and low-molecular-weight sensitizing agents causing occupational asthma: an evidence-based insight	8
Filgotinib in rheumatoid arthritis	8
Corticosteroid-eluting implants for the management of chronic rhinosinusitis with or without nasal polyps	8
Circulating NT-proANP level is a predictor of mortality for systemic sclerosis: a retrospective study of an Italian cohort	8
Biomarkers guiding biological therapeutic strategies in chronic rhinosinusitis with nasal polyps: an emerging challenge	7
Isolation and analysis of the exosomal membrane proteins in bullous pemphigoid	7
Mast cell activation: beyond histamine and tryptase	7
What is the relevance of FoxP3 in the tumor microenvironment and cancer outcomes?	7
CAR-T cell technologies that interact with the tumour microenvironment in solid tumours	7
Novel insights into central compartment atopic disease - a literature review	7
Managing psoriatic arthritis in different clinical scenarios	7
Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma	7
Tapinarof cream for the topical treatment of plaque psoriasis in adults	7
Role of CD68 in the tumor immune microenvironment in Hodgkin’s lymphoma	7
Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy	7
Genetic variations in the human immune system influence susceptibility to tegumentary leishmaniasis: a systematic review and meta-analysis	7
Dupilumab in chronic rhinosinusitis with nasal polyposis: current status, challenges, and future perspectives	7
Matrix metalloproteinases in chronic rhinosinusitis	7
Rationale for IL-37 as a novel therapeutic agent in inflammation	7
Pediatric chronic spontaneous urticaria: a brief clinician’s guide	7
Predicting the risk of relapse in polymyalgia rheumatica: novel insights	7
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications	7
The relationship between bullous pemphigoid and renal disease and related treatments: a review of the current literature	7
How should we approach management of childhood onset chronic anterior uveitis refractory to adalimumab?	6
The effect of intense pulsed light combined with topical 0.05% Cyclosporin A eyedrops in the treatment of Sjögren’s syndrome related dry eye	6
Ofatumumab subcutaneous injection for the treatment of relapsing forms of multiple sclerosis	6
Correction	6
Oral immunotherapy for food allergy in children: is it worth it?	6
Recent insights into the impacts of COVID-19 on pediatric asthma	6
Epstein–Barr virus-driven lymphoproliferation in inborn errors of immunity: a diagnostic and therapeutic challenge	6
Autoimmune hemolytic anemia: causes and consequences	6
How to and should we target EBV in MS?	6
Upadacitinib for the treatment of adult patients with active psoriatic arthritis	6
Biologics for Hidradenitis suppurativa: evolution of the treatment paradigm	6
Food immunotherapy: current status and future needs	6
Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives	6
Biological therapy in chronic rhinosinusitis with nasal polyps	6
Role of tight junction proteins in shaping the immune milieu of malignancies	6
Antiphospholipid antibodies and osteonecrosis in systemic lupus erythematosus: a meta-analysis	6
Intranasal corticosteroid and antihistamine combinations in the treatment of allergic rhinitis: the role of the novel formulation olopatadine/mometasone furoate	6
The clinical role of anakinra in the armamentarium against familial Mediterranean fever	6
Pharmacokinetics and pharmacodynamics of a proposed tocilizumab biosimilar MSB11456 versus both the US-licensed and EU-approved products: a randomized, double-blind trial	6
Machine learning and artificial intelligence within pediatric autoimmune diseases: applications, challenges, future perspective	6
An evaluation of the recently approved drugs for treating atopic dermatitis in the context of their safety and efficacy: a systematic review and meta-analysis	6
Tackling medical misinformation in allergy and immunology practice	6
Pathogen-specific cell-mediated immunity to guide the management of cytomegalovirus in solid organ transplantation: state of the art clinical review	6
Treatment controversies in spondyloarthritis and psoriatic arthritis: focus on biologics and targeted therapies	6
IRF1 expression might be a biomarker of CD8+ T cell infiltration in cutaneous melanoma	6
The oft-overlooked cardiovascular complications of inflammatory bowel disease	6
Tailored biological treatment for patients with moderate-to-severe psoriasis	5
Rare forms of inflammatory myopathies – part I, generalized forms	5
Classification and management strategies for paediatric chronic nonbacterial osteomyelitis and chronic recurrent multifocal osteomyelitis	5
How do nuclear factor kappa B (NF-κB)1 and NF-κB2 defects lead to the incidence of clinical and immunological manifestations of inborn errors of immunity?	5
Pathways of atopic disease and neurodevelopmental impairment: assessing the evidence for infant antibiotics	5

Assessment of anti-CD69 antibody therapy alone or in combination with anti-PD-1 in murine GBM	5
A critical review of halobetasol propionate foam (0.05%) as a treatment option for adolescent plaque psoriasis	5
Topical and systemic JAK inhibitors in hand eczema – a narrative review	5
Advances in therapeutic targeting of immune checkpoints receptors within the CD96-TIGIT axis: clinical implications and future perspectives	5
Evaluating the use of JAK inhibitors in inflammatory connective tissue diseases in pediatric patients: an update	5
Autoimmune disorders associated with common variable immunodeficiency: prediction, diagnosis, and treatment	5
Emergence of an adaptive immune paradigm to explain celiac disease: a perspective on new evidence and implications for future interventions and diagnosis	5
Plasma exchange as an adjunctive therapy in anti-neutrophil cytoplasm antibody-associated vasculitis	5
Subcutaneous immunoglobulin 20% (Ig20Gly) treatment regimens in pediatric patients with primary immunodeficiencies – real-world data from the IG TATRY study	5
Ixekizumab: an IL-17A inhibitor for the treatment of axial Spondylarthritis	5
LncRNA ZFAS1/miR-186-5p axis is involved in oxidative stress inhibition of myocardial ischemia-reperfusion injury by targeting BTG2	5
5 reasons to encourage anti-SARS-CoV-2 vaccination in patients with rheumatic diseases	5
Probiotics in asthma management: fiction or truth?	5
Transcriptional regulation of B cell class-switch recombination: the role in development of noninfectious complications	5
The role of complement and complement therapeutics in neuromyelitis optica spectrum disorders	5
Presentation and diagnosis of autoimmune lymphoproliferative syndrome (ALPS)	5
Recent insights into the pathogenesis of autoimmune hypophysitis	5
Nociplastic pain in axial spondyloarthritis and psoriatic arthritis: role of JAK kinases in immunopathology and therapeutic impact of JAK inhibitors	5
How effective are JAK-inhibitors? Perspectives from clinical trials and real-world studies	5
Early diagnosis of systemic sclerosis, where do we stand today?	5
Update on real-world use of facilitated subcutaneous immunoglobulin and immune globulin subcutaneous (human) 20% solution in patients with immunodeficiencies: poster extracts from the 19th Biennial Me	5
Endosomal Toll-Like Receptors intermediate negative impacts of viral diseases, autoimmune diseases, and inflammatory immune responses on the cardiovascular system	5
The emerging role of IL-23 in asthma and its clinical implications	5
Treatment of inflammatory complications in common variable immunodeficiency (CVID): current concepts and future perspectives	5
Durability and long-term outcomes of biologic therapies in psoriasis	5
Convalescent plasma and hyperimmune globulin therapy in COVID-19	5
Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus	5
Evaluating topical JAK inhibitors as a treatment option for atopic dermatitis	5
Comparing available treatments for pollen-induced allergic rhinitis in children	4
Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy	4
Biomarkers for systemic lupus erythematosus – a focus on organ damage	4
Epithelial cell dysfunction in chronic rhinosinusitis: the epithelial–mesenchymal transition	4
Pharmacokinetics and tolerability of prefilled syringe and auto-injector presentations of MSB11456: results of a randomized, single-dose study in healthy adults	4
Impact of anti-PD1 immunotherapy and circulating tumor cells on progression-free survival in surgical pancreatic adenocarcinoma: a retrospective cohort study	4
Teplizumab: promises and challenges of a recently approved monoclonal antibody for the prevention of type 1 diabetes or preservation of residual beta cell function	4
Treatment strategies for ANCA-associated vasculitides: from standard protocols to future horizons	4
Gut immune homeostasis: the immunomodulatory role of Bacillus clausii, from basic to clinical evidence	4
Considerations for managing elderly patients with atopic dermatitis	4
Biologics and atherosclerotic cardiovascular risk in rheumatoid arthritis: a review of evidence and mechanistic insights	4
Treatment of neuropsychiatric systemic lupus erythematosus: clinical challenges and future perspectives	4
An exercise immune fitness test to unravel mechanisms of Post-Acute Sequelae of COVID-19	4
Efgartigimod for generalized myasthenia gravis with or without anti-acetylcholine receptor antibodies: a worldwide and Japanese perspective	4
Conventional and new immunotherapies for immune system dysregulation in postpartum mood disorders: comparisons to immune system dysregulations in bipolar disorder, major depression, and postpartum aut	4
Management and treatment optimization of patients with mild to moderate ulcerative colitis	4
JAK inhibitors and black box warnings: what is the future for JAK inhibitors?	4
Ten clinical conundrums in the management of eosinophilic granulomatosis with polyangiitis	4
How suitable are JAK inhibitors in treating the inflammatory component in patients with alopecia areata and vitiligo?	4
Heterogeneity in myasthenia gravis: considerations for disease management	4
Pro-inflammatory cytokines in spondyloarthritis: a case-control study	4
Rheumatic masqueraders: mimics of primary vasculitis - a case-based review	4
Bimekizumab: a dual IL-17A and IL-17F inhibitor for the treatment of psoriasis and psoriatic arthritis	4
A comprehensive review on the role of mesenchymal stromal/stem cells in the management of rheumatoid arthritis	4
Pathological mechanisms of abnormal iron metabolism and mitochondrial dysfunction in systemic lupus erythematosus	4
Diagnosis and clinical management of Wiskott–Aldrich syndrome: current and emerging techniques	4
Establishing diagnostic strategies for cannabis allergy	4
Molecular investigations on T cell subsets in patients affected by hypomorphic DCLRE1C mutation	4
Direct economic burden 1 year postoperation in Chinese adult patients with chronic rhinosinusitis with nasal polyps	4
The management of women of childbearing age with rheumatoid arthritis: an expert report	4
Neurological adverse effects of chimeric antigen receptor T-cell therapy	4
Current treatment options and long-term outcomes in patients with eosinophilic esophagitis	4
Novel insights into the pathogenesis of virus-induced ARDS: review on the central role of the epithelial-endothelial barrier	4
The role of PCSK9 in inflammation, immunity, and autoimmune diseases	4
SLE criteria are by necessity still based on clinical (and immunological) criteria items	4
Patient-reported outcomes and realistic clinical endpoints for JAK inhibitors in rheumatoid arthritis	4
Serum exosomal long noncoding RNA nuclear-enriched abundant transcript 1 predicts 90-day mortality in acute-on-chronic hepatitis B liver failure	4
Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic	4
Interleukin polymorphisms and protein levels associated with lung cancer susceptibility and phenotypes	4
Therapeutic perspectives on the metabolism of lymphocytes in patients with rheumatoid arthritis and systemic lupus erythematosus	4
T-lymphocyte depleted transplants for inborn errors of immunity	3
Genetic susceptibility to inflammatory bowel disease: should we be looking to the hypothalamus?	3
Evaluation and management of dry mouth and its complications in rheumatology practice	3
Late effects following hematopoietic cell transplantation for severe combined immunodeficiency: critical factors and therapeutic options	3
CSE1L as a prognostic biomarker associated with pan cancer immune infiltration and drug sensitivity	3
Pathophysiology and management of Staphylococcus aureus in nasal polyp disease	3
Recent innovations in the screening and diagnosis of systemic sclerosis-associated interstitial lung disease	3
The GLP-1 receptor in airway inflammation in asthma: a promising novel target?	3
In-vitro assays for immuno-oncology drug efficacy assessment and screening for personalized cancer therapy: scopes and challenges	3
Antiphospholipid syndrome: the need for new international classification criteria	3
Patch testing while immunosuppressed: potential risks and benefits	3
The suitability of treating atopic dermatitis with Janus kinase inhibitors	3
Sicca syndrome/Sjögren’s disease associated with cancer immunotherapy: a narrative review on clinical presentation, biomarkers, and management	3
The “entanglement” between bullous pemphigoid and diabetes mellitus: a comprehensive review and expert recommendations	3
The role of histone deacetylases in inflammatory respiratory diseases: an update	3
DEL-1: a potential therapeutic target in inflammatory and autoimmune disease?	3
Clinical and immunologic implication of neo-osteogenesis in chronic rhinosinusitis	3
A comparative review of immunoassays for COVID-19 detection	3
JAK inhibitors, psoriatic arthritis, and axial spondyloarthritis: a critical review of clinical trials	3
Complement in autoimmune inflammatory myopathies, the role of myositis-associated antibodies, COVID-19 associations, and muscle amyloid deposits	3
Advancements in immunotherapy for advanced esophageal squamous cell carcinoma: a comprehensive review of current strategies and future directions	3
Exploring the relationship between house dust mites and asthma	3
Palindromic rheumatism: a unique and enigmatic entity with a complex relationship with rheumatoid arthritis	3
Real-world experience with subcutaneous infliximab: broadening treatment strategies for inflammatory bowel disease	3
Novel approaches to develop biomarkers predicting treatment responses to TNF-blockers	3
A review of genetic risk in systemic lupus erythematosus	3
Hematological involvement in sarcoidosis: from cytopenias to lymphoma	3